MSB 3.21% $1.13 mesoblast limited

To learn something new might not be the aim of a phase 3 trial...

  1. 1,254 Posts.
    lightbulb Created with Sketch. 1403
    To learn something new might not be the aim of a phase 3 trial but if something new turns up are you suggesting it be ignored?
    But as you say, the CHF phase 3 sure had a silver lining. A "new paradigm" in fact. Can't be ignored. However hard some people try.
    Last edited by benelong: 05/01/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.